Kestra Private Wealth Services LLC Has $842,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Kestra Private Wealth Services LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 25.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,365 shares of the financial services provider’s stock after buying an additional 1,284 shares during the period. Kestra Private Wealth Services LLC’s holdings in iShares Biotechnology ETF were worth $842,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. BNP Paribas Financial Markets raised its holdings in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $18,476,000. DRW Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $5,678,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.2 %

NASDAQ IBB opened at $137.04 on Friday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm’s 50 day moving average is $135.82 and its 200-day moving average is $141.11.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.